Specialty code 174400000X · Carmel, IN
NPI
1053307397
Since 2005
Specialty
Specialty code 174400000X
Code 174400000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
12772 Hamilton Crossing Blvd
Carmel, IN, 46032
Phone (317) 814-1000
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$933K
2,555 prescriptions
Company payments, 2025
$1,929
From 14 companies
Medicare prescription drug claims, 2024
In 2024, the drug Karin J Clary prescribed most often to Medicare patients was Buprenorphine-Naloxone (Buprenorphine Hcl/Naloxone Hcl), with 273 prescriptions and refills. In total Karin J Clary wrote 2,555 Medicare prescriptions that cost $933K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl | 273 | 289 | 42 | $32K |
| Buprenorphine Generic | 185 | 185 | 32 | $45K |
| Tizanidine Hcl Generic | 151 | 275 | 42 | $1,951 |
| Gabapentin Generic | 110 | 243 | 34 | $2,146 |
| Trazodone Hcl Generic | 99 | 245 | 33 | $1,541 |
| Naltrexone Hcl Generic | 70 | 122 | 20 | $4,103 |
| Pregabalin Generic | 62 | 122 | 17 | $2,889 |
| Propranolol Hcl Generic | 61 | 138 | 22 | $1,006 |
| Sertraline Hcl Generic | 58 | 139 | 18 | $572 |
| Lamotrigine Generic | 56 | 165 | 18 | $1,387 |
| Emgality Pen Galcanezumab-Gnlm | 52 | 64 | Under 11 | $45K |
| Venlafaxine Hcl Er Venlafaxine Hcl | 46 | 123 | 13 | $781 |
| Tramadol Hcl Generic | 41 | 41 | Under 11 | $201 |
| Buprenorphine Hcl Generic | 41 | 41 | Under 11 | $1,443 |
| Lidocaine Generic | 41 | 46 | Under 11 | $7,783 |
Brand drugs: 430 claims; generic drugs: 2,125 claims; opioid claims: 311.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Karin J Clary $1,929 ($1,929 in general payments such as food, travel and fees) from 14 companies. The largest payer was Abbvie Inc. with $651.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 40 | $651 |
| Teva Pharmaceuticals USA, Inc. TEVA | 26 | $476 |
| Pfizer Inc. PFE | 13 | $172 |
| Lundbeck LLC | 4 | $103 |
| Boston Scientific Corporation BSX | 3 | $86.94 |
| Collegium Pharmaceutical, Inc. COLL | 4 | $81.41 |
| Vanda Pharmaceuticals Inc. VNDA | 3 | $74.95 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 3 | $72.42 |
| Alkermes, Inc. ALKS | 2 | $52.07 |
| Axsome Therapeutics, Inc. AXSM | 2 | $41.84 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.